These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36289174)

  • 1. Community pharmacists' expanding roles in supporting patients before and during COVID-19: An exploratory qualitative study.
    Isenor JE; Cossette B; Murphy AL; Breton M; Mathews M; Moritz LR; Buote R; McCarthy L; Woodill L; Morrison B; Guénette L; Marshall EG
    Int J Clin Pharm; 2023 Feb; 45(1):64-78. PubMed ID: 36289174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient perspectives on the vital primary care role of community pharmacists in Nova Scotia, Canada: qualitative findings from the PUPPY Study.
    Isenor JE; Renaud L; Mathews M; Morrison B; Murphy AL; Bishop A; Bowles SK; Kennie-Kaulbach N; Peddle S; Breton M; Green ME; Marshall EG
    Int J Pharm Pract; 2024 May; 32(3):216-222. PubMed ID: 38484181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community pharmacists' roles during the closure stage of the COVID-19 pandemic in Newfoundland and Labrador, Canada: a qualitative case study.
    Farooq S; Donnan JR; Lukewich J; Mathews M; Lee TA
    BMJ Open; 2024 Aug; 14(8):e085338. PubMed ID: 39107026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 - an opportunity to improve access to primary care through organizational innovations? A qualitative multiple case study in Quebec and Nova Scotia (Canada).
    Breton M; Marshall EG; Deslauriers V; Smithman MA; Moritz LR; Buote R; Morrison B; Christian EK; McKay M; Stringer K; Godard-Sebillotte C; Sourial N; Laberge M; MacKenzie A; Isenor JE; Duhoux A; Ashcroft R; Mathews M; Cossette B; Hudon C; McDougall B; Guénette L; Kirkwood R; Green ME
    BMC Health Serv Res; 2022 Jun; 22(1):759. PubMed ID: 35676668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian community pharmacists' experiences during the COVID-19 pandemic.
    Kanaani E; Salahudeen MS; Curtain C
    Int J Pharm Pract; 2023 Sep; 31(5):472-477. PubMed ID: 37348933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A photovoice study on community pharmacists' roles and lived experiences during the COVID-19 pandemic.
    Watson KE; Schindel TJ; Chan JCH; Tsuyuki RT; Al Hamarneh YN
    Res Social Adm Pharm; 2023 Jun; 19(6):944-955. PubMed ID: 36935325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Never waste a good crisis": Opportunities and constraints from the COVID-19 pandemic on pharmacists' scope of practice.
    Chiu K; Thow AM; Bero L
    Res Social Adm Pharm; 2022 Sep; 18(9):3638-3648. PubMed ID: 35414485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic.
    Dwyer G; Popoola A; Seiler N; Therrien N; Karacuschansky A; Fulmer E; Horton K
    Prev Chronic Dis; 2022 Mar; 19():E10. PubMed ID: 35239471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased self-reported pharmacist prescribing during the COVID-19 pandemic: Using the Theoretical Domains Framework to identify barriers and facilitators to prescribing.
    Grant A; Rowe L; Kennie-Kaulbach N; Bishop A; Kontak J; Stewart S; Morrison B; Sketris I; Rodrigues G; Minard LV; Whelan AM; Woodill L; Jeffers E; Fisher J; Ricketts J; Isenor JE
    Res Social Adm Pharm; 2023 Jan; 19(1):133-143. PubMed ID: 36038458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical care tele-pharmacy services during COVID-19 pandemic: A qualitative exploration of healthcare practitioners' perceptions.
    Isleem N; Shoshaa S; AbuGhalyoun A; Khatib M; Naseralallah LM; Ibn-Mas'ud Danjuma M; Saad M
    J Clin Pharm Ther; 2022 Oct; 47(10):1591-1599. PubMed ID: 35699243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative analysis of student pharmacists' perceptions working in community settings during the COVID-19 pandemic.
    Bingham JM; Maldonado T; Axon DR
    Curr Pharm Teach Learn; 2024 Sep; 16(9):102104. PubMed ID: 38789297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coping strategies of community pharmacists and pharmaceutical services provided during COVID-19 in Malaysia.
    Kua KP; Lee SWH
    Int J Clin Pract; 2021 Dec; 75(12):e14992. PubMed ID: 34710264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C; Unni E; Montuoro J; Ogborn DB
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information.
    Hoti K; Jakupi A; Hetemi D; Raka D; Hughes J; Desselle S
    Int J Clin Pharm; 2020 Aug; 42(4):1197-1206. PubMed ID: 32524513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y; Sunderland B; Hughes J
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacists' role and experiences with delivering mental health care within team-based primary care settings during the COVID-19 pandemic.
    Ashcroft R; Mathers A; Gin A; Lam S; Donnelly C; Brown JB; Kourgiantakis T; Mehta K; Rayner J; Sur D; Adamson K; Kirvan A; Dolovich L
    Int J Pharm Pract; 2024 Mar; 32(2):156-163. PubMed ID: 38071626
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Patterson SM; Cadogan CA; Barry HE; Hughes CM
    BMJ Open; 2022 Sep; 12(9):e064549. PubMed ID: 36137632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries.
    Paudyal V; Cadogan C; Fialová D; Henman MC; Hazen A; Okuyan B; Lutters M; Stewart D
    Res Social Adm Pharm; 2021 Aug; 17(8):1507-1517. PubMed ID: 33288420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid realist review of the role of community pharmacy in the public health response to COVID-19.
    Maidment I; Young E; MacPhee M; Booth A; Zaman H; Breen J; Hilton A; Kelly T; Wong G
    BMJ Open; 2021 Jun; 11(6):e050043. PubMed ID: 34135054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.